Post by
canadafan on May 07, 2024 5:09pm
Yet another day gone by, very little if anything
So today, Tuesday. Not much happening.
Yet again, as I mentioned this am, there continues to be end of day support for the price.
Agreed, the volume & price movements quite insignificant.
What is interesting is the activity itself.
irinically bucky claims to be realistic?
A quick search of his posts....
zero, absolutely zero content of any value.
So far all he has materialized is random insults, none sense or put downs, either of other posters, or Onc itself.
Again, with zero substance.
Akin of grade school name calling.
Just a mindless, childish, eneducated troll.
Obviously desperatly trying to recover his short position.
bucky!want to gain some credibility?
comment, with some knowledge on the various trials?
I know you have a short memory & obviously can't read well, so a brief summary just for you.
1. Onc recently applied to FDA, to seek guidance & approval of the Aware-1, biomarkers, to be included in the phase 3 for MBc. Allowing such, will speed the phase 3 triall & allow Onc to pre- select participants thst are shown to react to Pela. The biomarkers can be detected within a simple blood test, after 2 weeks. ...existing chemo trials sometime require 6 weeks & various scans, to find out if the chemo is working or not.
Giving Pelareorep a huge comercial & clinical advantage.
2. They are waiting ..still for " events" aks deaths if mbc patients. To finalize the overall survival. Hard to grasp for those in a rush. Longer for O.S. Is better.
3. oncolytics biotech has two abstract presentations coming up next month.They would not be presenting bad news.
4.they were granted $500,000 towards an additional arm under the pancreatic cancer co- therapy.
I could go on.
All factual peer reviewed information.
actually every single update over the past 6 months has shown positive progress.
tomorrow yet another day.
regards
Comment by
JohnnyYeg on May 07, 2024 6:41pm
On point 4. they were granted $5,000,000 for the additional panc trial. ;) ;)